The Allstate Corporation (NYSE:ALL) Stock Has Average Target Price of $270.19

Shares of The Allstate Corporation (NYSE:ALL) have earned a consensus rating of “Hold” from the twenty-two brokerages that are covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation, eight have issued a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $270.19.

A number of analysts have recently weighed in on the stock. Citigroup lowered their price target on shares of Allstate from $240.00 to $215.00 and set a “sell” rating on the stock in a report on Friday, October 2nd. Barclays reduced their price objective on shares of Allstate from $226.00 to $221.00 and set an “underweight” rating for the company in a research note on Wednesday, October 7th. HSBC raised shares of Allstate from a “hold” rating to a “buy” rating and set a $266.00 target price for the company in a research report on Wednesday, October 7th. The Goldman Sachs Group decreased their target price on shares of Allstate from $280.00 to $250.00 and set a “neutral” rating for the company in a research report on Thursday, October 1st. Finally, Wall Street Zen upgraded shares of Allstate from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 17th.

Insiders Place Their Bets

In other news, COO Mario Rizzo sold 56,225 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the completion of the sale, the chief operating officer owned 82,227 shares in the company, valued at approximately $21,747,396.96. This represents a 40.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider John E. Dugenske sold 32,996 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $269.33, for a total value of $8,886,812.68. Following the completion of the sale, the insider directly owned 13,054 shares of the company’s stock, valued at $3,515,833.82. The trade was a 71.65% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.55% of the company’s stock.

Institutional Investors Weigh In On Allstate

Several institutional investors have recently added to or reduced their stakes in ALL. Kendall Capital Management increased its holdings in shares of Allstate by 2.4% in the 3rd quarter. Kendall Capital Management now owns 1,730 shares of the insurance provider’s stock valued at $384,000 after acquiring an additional 40 shares during the period. Cornerstone Financial Management LLC boosted its stake in Allstate by 24.9% during the 2nd quarter. Cornerstone Financial Management LLC now owns 226 shares of the insurance provider’s stock worth $54,000 after purchasing an additional 45 shares during the period. Capital Advisors Inc. OK grew its position in Allstate by 2.6% during the 2nd quarter. Capital Advisors Inc. OK now owns 1,827 shares of the insurance provider’s stock worth $435,000 after purchasing an additional 46 shares during the last quarter. Fifth Third Wealth Advisors LLC grew its position in Allstate by 0.8% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 5,871 shares of the insurance provider’s stock worth $1,303,000 after purchasing an additional 49 shares during the last quarter. Finally, Natural Investments LLC increased its stake in Allstate by 1.5% in the second quarter. Natural Investments LLC now owns 3,327 shares of the insurance provider’s stock valued at $791,000 after purchasing an additional 50 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

More Allstate News

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate prevailed in a Texas coverage dispute involving a vacant property. The ruling supports the insurer’s ability to enforce policy vacancy provisions, potentially limiting claims costs and reinforcing underwriting discipline. Vacant clause can void cover: US court backs Allstate in Texas case
• Positive Sentiment: Allstate retained $9,000 in a subrogation-related dispute after a court placed the premature filing cost on the opposing liability carrier. The financial impact is small, but the decision may support Allstate’s claims-handling position. Allstate keeps $9,000 as premature subrogation cost falls on liability carrier
• Positive Sentiment: Bank of America raised its price target on Allstate to $340 from $336, signaling continued confidence in the insurer’s earnings outlook and valuation. BofA raises target from $336 to $340
• Positive Sentiment: A valuation-focused analysis said Allstate still appears inexpensive despite a 131% advance, potentially attracting investors who expect further benefits from strong insurance pricing and improved profitability. Allstate stock still looks cheap after its 131% run
• Neutral Sentiment: Allstate shares gained 3.76% in the referenced session, although KBW maintained its Sell rating, highlighting a disconnect between short-term trading momentum and analyst conviction. KBW keeps Sell rating
• Neutral Sentiment: UBS reiterated its Hold rating, offering no new catalyst but indicating the firm sees limited justification for changing its current view. UBS keeps Hold rating
• Negative Sentiment: Analysts expect Allstate’s third-quarter earnings per share to decline by double digits year over year, creating concern ahead of the company’s November earnings release. What to expect from Allstate’s next quarterly earnings report
• Negative Sentiment: KBW’s continued Sell rating remains a notable overhang, suggesting the firm believes Allstate’s strong rally has outpaced its fundamental value. KBW keeps Sell rating
• Negative Sentiment: The price target for Allstate’s preferred stock was reduced 12.29% to $19.21, signaling weaker expectations for that security, although it does not directly change the valuation of the common shares. Allstate preferred stock price target decreased

Allstate Price Performance

Shares of ALL stock opened at $253.24 on Wednesday. Allstate has a 1-year low of $188.08 and a 1-year high of $277.22. The stock’s 50-day moving average is $245.78 and its 200 day moving average is $236.63. The company has a market cap of $64.03 billion, a P/E ratio of 5.06, a PEG ratio of 0.57 and a beta of 0.13. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.06 by $2.93. The company had revenue of $18.60 billion for the quarter, compared to analyst estimates of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%. The firm’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.94 earnings per share. Research analysts predict that Allstate will post 36.21 earnings per share for the current fiscal year.

About Allstate

Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.